TPD52 and breast carcinoma: The results indicated high expression of TPD52 (p = 0.0017) (Figure 8(a)) and low expression of KLF3 (p = 0.0048) (Figure 8(b)), miR-124 (p = 0.0048) (Figure 8(c)), and PKCε (p = 0.0043) (Figure 8(d)) in blood of breast cancer patients as compared to healthy controls.